1.37

0.72% -0.010

After Hours: 1.33 -0.04 -2.92%

Calidi Biotherapeutics Inc (CLDI)

Overview News Price History Discussions Forecast

Calidi Biotherapeutics Inc stock is traded at $1.37, with a volume of 125.49K. It is down -0.72% in the last 24 hours and down -9.87% over the past month. Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.

Previous Close:

$1.38

Open:

$1.35

24h Volume:

125.49K

Relative Volume:

0.56

Market Cap:

$9.82M

Revenue:

Net Income/Loss:

$-23.36M

P/E Ratio:

-1.8594

EPS:

-0.7368

Net Cash Flow:

1W Performance:

-8.67%

1M Performance:

-9.87%

6M Performance:

-71.82%

1Y Performance:

-94.69%

1-Day Range:

$1.2875

$1.414

1-Week Range:

$1.2875

$1.54

52-Week Range:

$1.10

$27.63

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name

Calidi Biotherapeutics Inc

Sector

Healthcare (1129)

Industry

Biotechnology (632)

Phone

(858) 794-9600

Address

4475 Executive Drive, Suite 200, San Diego

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CLDI's Discussions on Twitter

Compare CLDI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLDI Calidi Biotherapeutics Inc	1.37	9.89M	0	-23.36M	0	-0.7368
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-22-23	Initiated	H.C. Wainwright	Buy
Oct-09-23	Initiated	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Stock (CLDI) Latest News

06:16 AM

What margin trends mean for Calidi Biotherapeutics Inc. stockMarket Growth Summary & Daily Chart Pattern Signals - newser.com

06:16 AM

02:11 AM

Will Calidi Biotherapeutics Inc. stock outperform small cap peersPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com

02:11 AM

Nov 20, 2025

Will Calidi Biotherapeutics Inc. stock recover faster than industryTrade Exit Report & Weekly High Conviction Trade Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

Will Calidi Biotherapeutics Inc. stock sustain bullish trend into 2025 - newser.com

Nov 19, 2025

Will Calidi Biotherapeutics Inc. stock benefit from commodity pricesAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com

Nov 19, 2025

Why Calidi Biotherapeutics Inc. stock stays undervaluedWeekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com

Nov 19, 2025

Calidi Biotherapeutics Inc.’s volatility index tracking explainedJuly 2025 Review & Entry Point Confirmation Signals - newser.com

Nov 19, 2025